Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1997-1-10
|
pubmed:abstractText |
1. The present study was undertaken to compare the effects of beraprost sodium (BPS), a stable prostaglandin I2 analog, with prostaglandin E1 (PGE1) on the skin blood flow in anesthesized diabetic rats and anesthetized dogs. 2. In anesthetized diabetic rats, BPS, but not PGE1, caused a dose-dependent and significant increase in femoral skin blood flow. 3. In anesthetized dogs, PGE1 significantly increased femoral arterial blood flow than BPS. However, BPS significantly increased in-step skin blood flow than PGE1. 4. The above data suggest that BPS may be clinically useful for the treatment of circulatory insufficiency of lower extremities in diabetic patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0306-3623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
333-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8919652-Alprostadil,
pubmed-meshheading:8919652-Animals,
pubmed-meshheading:8919652-Diabetes Mellitus, Experimental,
pubmed-meshheading:8919652-Dogs,
pubmed-meshheading:8919652-Dose-Response Relationship, Drug,
pubmed-meshheading:8919652-Epoprostenol,
pubmed-meshheading:8919652-Female,
pubmed-meshheading:8919652-Male,
pubmed-meshheading:8919652-Platelet Aggregation Inhibitors,
pubmed-meshheading:8919652-Rats,
pubmed-meshheading:8919652-Regional Blood Flow,
pubmed-meshheading:8919652-Skin
|
pubmed:year |
1996
|
pubmed:articleTitle |
Effects of beraprost sodium and prostaglandin E1 on skin blood flow in diabetic rats and normal dogs.
|
pubmed:affiliation |
Basic Research Laboratories, Toray Industries Inc., Kanagawa, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|